C6ORF35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.219800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.606800E-01
Normal-vs-Stage2
2.713200E-01
Normal-vs-Stage3
7.401600E-01
Normal-vs-Stage4
3.647000E-01
Stage1-vs-Stage2
9.099800E-01
Stage1-vs-Stage3
8.038400E-01
Stage1-vs-Stage4
8.221600E-01
Stage2-vs-Stage3
6.063200E-01
Stage2-vs-Stage4
8.276600E-01
Stage3-vs-Stage4
7.032800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.316000E-01
Normal-vs-AfricanAmerican
6.175200E-01
Normal-vs-Asian
3.230800E-01
Caucasian-vs-AfricanAmerican
7.200400E-01
Caucasian-vs-Asian
4.645000E-01
AfricanAmerican-vs-Asian
4.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.349200E-01
Normal-vs-Female
5.433600E-01
Male-vs-Female
2.666600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.528400E-01
Normal-vs-Age(41-60Yrs)
7.395000E-01
Normal-vs-Age(61-80Yrs)
3.183600E-01
Normal-vs-Age(81-100Yrs)
3.367000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.598880E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.125200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.797200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.442000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.988200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.350000E-01
Normal-vs-Daily Drinker
1.139450E-01
Normal-vs-Weekly Drinker
7.011700E-02
Normal-vs-Occasional Drinker
9.629400E-01
Normal-vs-Social Drinker
3.514600E-01
Non Drinker-vs-Daily Drinker
6.792400E-01
Non Drinker-vs-Weekly Drinker
4.559000E-01
Non Drinker-vs-Occasional Drinker
1.378400E-01
Non Drinker-vs-Social Drinker
7.912800E-01
Daily Drinker-vs-Weekly Drinker
6.024200E-01
Daily Drinker-vs-Occasional Drinker
9.920300E-02
Daily Drinker-vs-Social Drinker
4.656800E-01
Weekly Drinker-vs-Occasional Drinker
5.906200E-02
Weekly Drinker-vs-Social Drinker
2.861000E-01
Occasional Drinker-vs-Social Drinker
2.669600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.325400E-01
Normal-vs-Grade 2
6.121200E-01
Normal-vs-Grade 3
1.573650E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.748800E-01
Grade 1-vs-Grade 3
5.215200E-01
Grade 1-vs-Grade 4
2.325400E-01
Grade 2-vs-Grade 3
9.784200E-01
Grade 2-vs-Grade 4
6.121200E-01
Grade 3-vs-Grade 4
1.573650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.346200E-01
Normal-vs-NonDiabetic
4.244800E-01
Diabetic-vs-NonDiabetic
4.036400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.120800E-01
Normal-vs-NoPancreatitis
4.419600E-01
Pancreatitis-vs-NoPancreatitis
4.311600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.984000E-01
Normal-vs-N1
3.041400E-01
N0-vs-N1
4.862600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.518000E-01
Normal-vs-TP53-NonMutant
6.468400E-01
TP53-Mutant-vs-TP53-NonMutant
6.666400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
